Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies
Cloudbyz
MARCH 6, 2024
Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Biosimilars have the potential to lower healthcare costs, increase market competition, and improve patient access to biologic therapies.
Let's personalize your content